Image Dominic Tyer An editor and writer specialising in pharma, biotech and healthcare, Dominic Tyer is pharmaphorum's creative and editorial director and interim managing editor. Digital Pharma in the age of acceleration Syneos Health tracks the future paths for healthcare technology to identify what will be truly disruptive for the pharmaceutical industry. News The Havas Lynx Group appoints a brace of creative directors The Havas Lynx Group has bolstered its creative team, appointing Paul Watson and Nick Craske as creative directors. Digital The age of digital medicine is here As technology and traditional healthcare converge, some trends in cutting-edge digital health innovation are emerging. R&D Opening doors in pharmaceutical development Evidera surveys the adoption of machine learning by the pharmaceutical industry and looks at how it can increase R&D efficiencies. Load more results
Digital Pharma in the age of acceleration Syneos Health tracks the future paths for healthcare technology to identify what will be truly disruptive for the pharmaceutical industry.
News The Havas Lynx Group appoints a brace of creative directors The Havas Lynx Group has bolstered its creative team, appointing Paul Watson and Nick Craske as creative directors.
Digital The age of digital medicine is here As technology and traditional healthcare converge, some trends in cutting-edge digital health innovation are emerging.
R&D Opening doors in pharmaceutical development Evidera surveys the adoption of machine learning by the pharmaceutical industry and looks at how it can increase R&D efficiencies.
News Ipsen' Bylvay fluffs its lines in biliary atresia trial Ipsen's IBAT inhibitor Bylvay has failed a trial in biliary atresia, a rare and serious liver disease that affects babies and has limited treatments.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
